SHUTTLE PHARMACEUTICALS HOLDINGS INC (SHPH)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
$5.21+1.17%
Close 2026-11-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
QuarterlyIQ Insights · SHPH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of —
SHPH — legal / regulatory event — Changes in Registrant’s Certifying Accountant
Dated 2026-10-22
Changes in Registrant’s Certifying Accountant. Dismissal of Independent Registered Public Accounting Firm. On October 16, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of Shuttle Pharmaceuticals Holdings, Inc. (the “Company”), and the full Board, approved the dismissal of Forvis Mazars, LLP (“Forvis Mazars”) as the Company’s independent registered public accounting firm, effective following the filing of the Company’s Quarterly Report on Form 10-Q f…
Why it matters: United Dogecoin is assessing power and data centre assets in both regions. A signed deal would show progress beyond evaluation.
Supportive ifA filing or company release names an Idaho or Alberta power asset and its deal terms. It also shows a clear path to use the asset for mining or computing.
Worry ifA company update says no power or data centre deal was reached, or that the review was dropped.
Why it matters: Current signals flag losses and capital actions that can dilute shares. The update can show whether cash needs remain high.
Worry ifThe November 12 report shows losses continued. It also shows another new share or warrant issue to fund operations.
Less concerning ifThe report shows lower losses and no new share or warrant issue for operating cash.
Why it matters: The company said its first ElphaPex miners were arriving at a hosted site. A live deployment would test whether mining has begun.
Supportive ifA company update states how many miners are energized and how much DOGE they mined.
Worry ifA company update says miners are still not energized, or reports no DOGE mined from the first units.
Why it matters: The filing delay led to a Nasdaq notice. The report would show whether the company has filed and addressed its listing issue.
Worry ifThe Form 10-Q remains unfiled, or the next filing reports that Nasdaq has not accepted a plan to regain compliance.
Less concerning ifThe company files the Form 10-Q and reports that Nasdaq accepted its plan to regain compliance.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$446 on $10,000 · ±4.5% | How much price usually moves either way. |
| Bad day | $1,322 loss on $10,000 · 13.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,038 loss on $10,000 · 90.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Nasdaq acceptance could give the company time to fix its filing problem. Rejection would leave the listing at risk.
Watch forNasdaq accepts the plan and grants an extension to file by February 22, 2027, or earlier.
Also watch forNasdaq rejects the plan, or the company misses the February 22, 2027 deadline and fails to regain compliance.